Rigel Pharmaceuticals, Inc. (RIGL)
30.68
+0.60
(+1.98%)
USD |
NASDAQ |
Jun 09, 16:00
30.68
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals SG&A Expense (Quarterly) : 30.65M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.961B |
| Madrigal Pharmaceuticals, Inc. | 268.52M |
| CytomX Therapeutics, Inc. | 10.69M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |